Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Accumulated Expenses (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Accumulated Expenses data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Accumulated Expenses fell 7.92% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $2.2 million, down 7.92%, while the annual FY2024 figure was $3.1 million, 136.55% up from the prior year.
  • Accumulated Expenses reached $2.2 million in Q3 2025 per UTMD's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $5.0 million in Q1 2023 and bottomed at $1.2 million in Q4 2021.
  • Average Accumulated Expenses over 5 years is $3.4 million, with a median of $3.6 million recorded in 2022.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 287.1% in 2022, then crashed 72.71% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $1.2 million in 2021, then surged by 287.1% to $4.7 million in 2022, then plummeted by 72.71% to $1.3 million in 2023, then surged by 136.55% to $3.1 million in 2024, then fell by 26.72% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $2.2 million in Q3 2025, $1.5 million in Q2 2025, and $3.4 million in Q1 2025.